physiolog
pharmacolog
role
nucleic
acid
structur
fold
non
canon
gquadruplex
conform
recent
emerg
activ
target
vital
cellular
process
includ
telomer
mainten
regul
transcript
process
premesseng
telomer
rna
addit
sever
condit
like
cancer
fragil
x
syndrom
bloom
syndrom
werner
syndrom
fanconi
anemia
j
relat
genom
defect
involv
gquadruplex
form
sequenc
connect
gquadruplex
recognit
process
nucleic
acid
direct
protein
enzym
repres
key
event
activ
deactiv
physiolog
patholog
pathway
review
examin
proteingquadruplex
recognit
physiolog
signific
condit
discuss
possibl
exploit
interact
select
target
therapeut
intervent
grich
dna
rna
sequenc
fold
quadruplex
consist
non
canon
structur
stabil
stack
gquartet
four
guanin
assembl
planar
arrang
hoogsteen
hydrogen
bond
character
rel
direct
parallel
vs
antiparallel
strand
connect
guanin
syn
vs
anti
glycosyl
conform
natur
length
geg
connect
loop
intrav
intermolecular
natur
structur
number
stack
tetrad
addit
conform
properti
larg
influenc
environment
condit
particular
presenc
monoval
ion
k
na
featur
grant
high
degre
polymorph
arrang
make
suitabl
differenti
recognit
addit
rel
mild
chang
experiment
set
addit
specif
low
molecular
weight
ligand
may
lead
grich
sequenc
foldunfold
henc
confer
characterist
molecular
switch
due
properti
gquadruplex
structur
repres
novel
nucleic
acid
arrang
worth
scientif
investig
also
emerg
biolog
signific
due
presenc
grich
sequenc
specif
region
genom
particular
guanin
overrepres
termin
repeat
sequenc
chromosom
telomer
promot
region
gene
especi
protooncogen
cmyc
ckit
vegf
hra
nra
well
human
gene
addit
select
form
rna
level
contribut
modul
inform
flow
lead
protein
find
suggest
role
control
biolog
event
includ
chromosom
protect
gene
express
forese
sever
potenti
biophys
diagnost
therapeut
applic
recent
review
cover
matter
thoroughli
effect
regul
physiolog
patholog
process
consid
two
way
exploit
target
protein
intervent
thu
modul
basal
activ
altern
potenti
use
nonphysiolog
player
produc
desir
cellular
effect
latter
concept
evidenc
activ
exhibit
fold
sequenc
aptam
toward
select
target
strong
affin
specif
make
sort
nucleic
acidbas
antibodi
recent
review
see
refer
review
consid
recent
inform
avail
role
play
interact
protein
unravel
natur
occur
recognit
regul
pathway
physiolog
patholog
relev
help
identifi
yet
undisclos
nonphysiolog
nucleic
acid
structur
aptam
abl
interfer
biolog
process
approach
subject
wish
remind
follow
import
issu
relev
discuss
ie
specif
interact
occur
vitro
repres
safe
proof
exist
interact
vivo
plastic
structur
easili
undergo
conform
chang
recognit
process
coexist
differ
structur
divers
bind
affin
given
target
present
threedimension
structur
complex
avail
render
molecular
model
ration
target
difficult
task
vitro
select
recognit
proteindirect
aptam
aptam
nucleic
acid
sequenc
abl
appropri
fold
specif
recogn
target
molecul
specif
reminisc
exhibit
antibodi
aptam
includ
potenti
applic
anticoagul
antivir
antirheumat
antiproliferart
agent
biosensor
recent
review
see
refer
although
repres
one
sever
possibl
option
aptam
architectur
conspicu
number
aptam
report
celebr
one
thrombinbind
ggttggtgtggttgg
encompass
two
tetrad
complex
thrombin
provid
one
xray
structur
bound
protein
thu
far
avail
fig
aptam
sandwich
two
thrombin
molecul
bind
larg
salt
bridg
fibrinogen
exosit
one
heparin
bind
site
ctermin
region
thrombin
molecul
tgt
sequenc
form
one
three
loop
involv
hydrophob
cluster
near
fibrinogen
exosit
ile
ile
tyr
wherea
belong
one
tt
loop
associ
pro
trp
heparin
bind
site
thu
electrostat
hydrophob
interact
explain
stabil
recognit
complex
current
advanc
refer
improv
thrombin
aptam
deriv
incorpor
unlock
nucleotid
monom
una
lack
cec
bond
dribos
moieti
posit
substitut
dribos
una
deriv
may
produc
either
destabil
stabil
aptam
structur
depend
upon
posit
along
dna
chain
like
relat
higher
degre
local
flexibl
produc
open
ribos
particularli
effect
oligom
modifi
posit
found
effici
origin
aptam
protein
bind
anticoagul
activ
target
vegf
aptam
rais
growth
factor
receptorbind
domain
identifi
tgtgggggtg
gacgggccgggtaga
show
bind
constant
nanomolar
rang
pharmacolog
interest
relat
fact
share
target
macugen
pegaptanib
non
rnabas
aptam
clinic
approv
wet
macular
degener
emphas
potenti
clinic
applic
aptam
cancer
chemotherapeut
grich
oligonucleotid
ggtggtggtggttgtggtggtggtgg
discov
year
ago
undergo
phase
ii
clinic
trial
treatment
aml
renal
cell
carcinoma
surprisingli
form
potenti
seem
repres
gener
featur
lead
cancerselect
antiprolif
activ
shown
impress
data
refer
synthet
grich
oligonucleotid
librari
potenti
clinic
use
target
also
nonhuman
protein
exampl
tetraend
link
oligonucleotid
cluster
four
tg
sequenc
arrang
parallel
investig
antihiv
activ
show
potenc
submicromolar
rang
author
specul
conserv
residu
hypervari
loop
repres
key
site
aptam
bind
recognit
gener
driven
electrostat
forc
final
field
aptam
recognit
also
profit
exploit
develop
biosens
system
analyt
applic
use
logic
gate
strategi
recent
synthet
receptor
gener
function
sequenc
specif
octanucleotid
g
stretch
fit
target
protein
surfac
sens
specif
interven
contact
assembl
dna
quadruplex
modifi
three
fluorophor
exhibit
individu
overlap
emiss
spectra
produc
distinct
emiss
pattern
interact
differ
protein
observ
differ
use
monitor
protein
concentr
level
investig
analyt
combin
produc
conform
chang
probe
list
aptam
recogn
specif
protein
target
report
tabl
use
sort
mirror
approach
anoth
line
research
led
major
advanc
product
develop
antibodi
peptid
sequenc
abl
bind
effici
one
first
exampl
concern
highaffin
subnanomolar
rang
singlechain
antibodi
fragment
abl
recogn
form
stylonychia
lemna
telomer
repeat
peculiarli
protein
effect
discrimin
parallel
antiparallel
quadruplex
conform
form
sequenc
find
singlechain
antibodi
react
specif
macronucleu
lemna
produc
clearcut
evid
inde
repres
biolog
relev
structur
form
telomer
live
cell
absenc
antibodi
bind
replic
band
region
telomer
replic
elong
occur
indic
reason
resolv
stage
semin
result
develop
explor
possibl
gener
biolog
signific
structur
select
recognit
recent
singlechain
antibodi
select
phage
display
competit
select
report
effect
recognit
intramolecular
clearli
discrimin
two
parallel
arrang
found
protooncogen
promot
furthermor
author
select
singlechain
bind
antibodi
method
compar
report
neg
select
duplex
dna
identifi
protein
show
broad
rang
affin
toward
select
genom
sequenc
detect
bind
duplex
dna
antibodi
henc
repres
valuabl
tool
investig
exist
function
within
genom
fact
correl
found
effect
antibodi
upon
gene
express
occurr
put
quadruplex
sequenc
either
promot
terminu
gene
interestingli
product
antibodi
human
cell
significantli
upor
downregul
gene
express
suggest
regulatori
role
process
antibodi
protein
select
recogn
inde
chemic
modifi
three
zinc
finger
motif
identifi
effect
ligand
screen
peptid
librari
obtain
phage
display
effect
polypeptid
found
inhibit
dna
polymeras
telomeras
action
templat
contain
telomer
repeat
concentr
nanomolar
rang
mutat
bind
studi
show
singl
zinc
finger
replac
anoth
known
finger
without
signific
loss
bind
affin
wherea
two
simultan
replac
deleteri
recognit
finger
crucial
element
quadruplex
complex
possibl
physiolog
occurr
origin
locat
telomer
nucleoprotein
complex
end
chromosom
dna
compon
character
repeat
grich
sequenc
ttaggg
human
inde
mani
stem
telomer
fragment
character
xray
spectroscop
techniqu
shown
inde
arrang
varieti
architectur
mani
factor
like
play
role
foldingeunfold
equilibria
telomer
dna
first
occurr
complex
loop
organ
dlooptloop
mask
telomer
end
repair
machineri
second
presenc
sever
function
protein
bound
telomer
produc
addit
level
complex
fact
protein
could
act
chaperon
favor
recruit
stabl
quadruplex
structur
contrari
could
bind
preferenti
unfold
form
henc
shift
equilibrium
away
fold
case
propens
dna
sequenc
modul
protein
assembl
dna
process
telomer
vertebr
telomer
dna
cap
group
six
protein
assum
name
shelterin
compris
directli
bind
duplex
structur
interact
singlestrand
overhang
tail
addit
bind
directli
dna
requir
complet
nucleoprotein
complex
creat
function
network
connect
compon
altern
cap
pathway
first
describ
bud
yeast
involv
heterotrim
complex
name
cst
requir
telomer
stabil
wide
rang
eukaryot
even
presenc
shelterin
protein
confirm
protein
respons
fine
tune
conform
equilibria
telomer
portion
undergo
directli
involv
telomer
preserv
also
regul
telomeras
activ
known
sinc
year
telomeras
unabl
elong
fold
substrat
principl
justifi
chemotherapeut
approach
base
stabil
howev
dna
bind
protein
promot
telomer
level
oxytricha
nova
end
macronuclear
chromosom
bound
telomer
endbind
protein
tebp
protein
form
two
subunit
b
tebpa
effici
bind
singl
strand
telomer
repeat
alloc
deep
cleft
tebpb
heterodimer
presenc
dna
lead
b
singlestrand
ss
dna
ternari
complex
nucleic
acid
bound
ntermin
domain
globular
region
b
although
b
subunit
bind
termin
telomer
repeat
greatli
acceler
format
oligonucleotid
substrat
correspond
oxytricha
g
g
tetrahymena
g
g
telomer
repeat
physiolog
condit
interestingli
higher
resolut
electron
densiti
map
mention
ternari
complex
evidenc
addit
bind
structur
locat
apart
ssdna
bind
site
fig
complex
tebp
contact
fold
dna
interact
extens
electrostat
type
addit
proteinenucl
acid
contact
surfac
rel
small
structur
data
clear
observ
bind
physiolog
relev
could
promot
crystal
packag
inde
ctermin
basic
domain
b
subunit
absent
crystal
complex
actual
consid
bind
element
interestingli
stabil
effect
shown
modul
vivo
cell
cycl
depend
protein
phosphoryl
howev
prefer
stabil
antiparallel
arrang
demonstr
result
copres
b
subunit
b
subunit
subsequ
shown
partial
sequenc
homolog
shelterin
wherea
tebpa
correspond
vertebr
nevertheless
interact
unfold
allow
telomeras
action
protein
form
stoichiometr
complex
fold
dna
melt
free
terminu
therebi
allow
telomer
elong
conclus
drawn
use
fission
yeast
mous
telomer
dna
presenc
dna
bind
domain
type
structur
recogn
protein
possibl
antiparallel
yeast
bind
mode
similar
share
among
multipl
role
regul
telomer
mainten
promot
partial
denatur
organ
counterpart
repres
similarli
tebpb
stabil
promot
mg
depend
manner
mechan
import
vivo
function
shown
mutant
defici
stimul
produc
gradual
telomer
shorten
cellular
senesc
experiment
find
indic
necessari
catalyt
activ
import
telomeras
regul
far
effect
telomer
protein
rap
role
possibl
rest
protect
gstrand
telomer
overhang
recogn
singlestrandeddoublestrand
dna
interfac
inde
assembl
difficulti
presenc
overhang
howev
involv
dna
repair
protein
wrn
inhibit
show
combin
protein
machineri
telomer
substanti
impair
line
preval
protein
effect
intramolecular
fold
circular
dichroism
plasmid
uptak
investig
indic
argrich
ntermin
trf
domain
stimul
format
parallel
intramolecular
presenc
potassium
ion
sodium
ion
case
yeast
homologu
addit
trfh
oligomer
domain
produc
singl
strand
oligonucleotid
intermolecular
parallelstrand
structur
addit
presenc
trf
overcam
gquadruplexdepend
inhibit
anneal
stimul
telomer
oligonucleotid
uptak
result
point
differ
handl
abil
two
protein
domain
taken
togeth
result
far
discuss
indic
import
conserv
vivo
function
role
play
format
disrupt
telomeras
regul
process
tebpa
trf
exhibit
unfold
properti
counterbalanc
stimul
effect
exhibit
tebpb
besid
telomer
relev
proteic
complex
form
shelterin
cst
protein
recruit
telomer
particular
phase
cell
cycl
content
repres
relev
factor
control
recruit
factor
appropri
regul
protein
bind
event
import
process
involv
protein
local
telomer
level
dna
damag
sens
repair
carri
human
heterotrimer
complex
mrn
homolog
yeast
mrx
complex
form
stoichiometri
interestingli
possess
much
higher
affin
sequenc
nt
resembl
telomer
array
singleor
doublestrand
dna
complex
stimul
endonucleas
activ
site
flank
bind
site
activ
might
requir
produc
free
end
serv
substrat
subsequ
action
helicas
telomeras
remark
prefer
singlestrand
dna
conserv
also
mrx
heterotrim
complex
suppress
endonucleas
exonucleas
activ
saccharomyc
cerevisia
consequ
cleavag
select
site
occur
singlestrand
g
residu
doublestrand
dna
tg
step
compris
also
arrang
suggest
role
telomer
homeostasi
analog
also
replic
protein
rpa
involv
dna
repair
telomer
mainten
human
rpa
bind
unfold
form
complex
linear
telomer
sequenc
first
bind
step
propos
destabil
structur
unfold
dna
bound
one
hrpa
molecul
extrem
facilit
bind
second
rpa
molecul
produc
complex
interestingli
rpa
known
inhibit
stimul
telomeras
activ
depend
upon
protein
concentr
might
correl
format
two
type
complex
spectroscop
electrophoret
studi
show
rpa
recogn
unwind
nontelomer
intramolecular
arrang
physiolog
signific
environ
howev
complex
also
bind
complementari
pyrimidin
rich
strand
wherea
bind
anneal
doublestrand
structur
final
atrx
wide
express
chromatinassoci
protein
link
syndrom
mental
retard
mechan
action
protein
recent
examin
shown
associ
telomer
modul
histon
replac
interestingli
atrx
target
dna
region
potenti
form
dna
bind
effici
sequenc
exhibit
parallel
antiparallel
structur
therebi
suggest
mechan
select
protein
nucleic
acid
recognit
possibl
oper
also
nontelomer
region
helicas
dnarna
unwind
enzym
use
atp
energi
sourc
helicas
gener
work
duplex
structur
abl
unwind
number
non
canon
arrang
includ
crucial
maintain
integr
repetit
grich
region
genom
sever
helicas
famili
includ
recq
hwrn
hblm
sgsl
fancj
dogl
rtel
known
process
telomer
gener
reduc
level
helicas
direct
toward
grich
region
work
telomerasedepend
cell
well
cell
use
nonconserv
recombinationmedi
telomer
lengthen
alt
pathway
defici
activ
helicas
caus
sever
impair
dna
process
aberr
genet
recombin
andor
dna
replic
expect
inactiv
mutat
produc
domin
neg
phenotyp
dna
replic
dna
damag
respons
protein
traffick
impair
sever
critic
patholog
condit
known
associ
autosom
recess
mutat
gene
code
helicas
among
bloom
syndrom
associ
enhanc
rate
leukemia
solid
tumor
sarcoma
wherea
werner
syndrom
character
prematur
occurr
agerel
symptom
includ
diabet
arteriosclerosi
atherosclerosi
osteoporosi
addit
condit
produc
unusu
high
incid
cancer
final
fanconi
anemia
j
produc
bone
marrow
failur
predisposit
cancer
due
well
establish
correl
genet
defect
onset
diseas
helicas
intens
investig
full
pictur
biolog
function
dissect
remark
extent
concern
wrn
blm
particip
dna
replic
recombin
repair
process
nucleic
acid
direction
human
helicas
normal
unwind
particular
wrn
effici
unwind
bimolecular
obtain
nucleotid
repeat
cgg
n
relat
fragil
x
syndrom
see
presenc
atp
mg
interestingli
unwind
wrn
replicationblock
domain
dna
templat
enabl
dna
polymeras
travers
hinder
grich
dna
tract
tetraplex
structur
must
embed
linear
filament
resolv
sinc
bluntend
sequenc
process
tetramolecular
henc
helicas
exhibit
well
defin
requisit
dna
recognit
depend
upon
molecular
sequenc
characterist
tetraplex
substrat
although
wrn
belong
recq
helicas
famili
requir
dna
substrat
conserv
member
famili
exampl
helicas
unwind
even
presenc
protein
helicas
cofactor
rpa
effect
resolv
holliday
junction
thu
highlight
substanti
differ
complementari
function
cover
differ
member
recq
famili
subsequ
studi
bind
select
show
mandatori
prerequisit
wrn
initi
unwind
presenc
singlestrand
sequenc
end
similar
requir
hold
blm
bind
within
gloop
princip
site
bind
fork
dna
well
structur
locat
conserv
rqc
domain
consist
zn
bind
region
wing
helix
subdomain
unexpectedli
recent
realtim
fluoresc
studi
show
blm
poorli
effect
unwind
intramolecular
adopt
differ
natur
sequenc
unwound
doublestrand
dna
far
effici
challeng
inform
thu
far
avail
although
obtain
intramolecularli
fold
case
quadruplex
format
interpret
obstacl
henc
modul
element
enzym
transloc
along
dna
sinc
oxid
dg
repres
one
princip
product
oxid
dna
damag
molecular
mechan
recognit
examin
substitut
dg
blm
quadruplex
substrat
interestingli
modifi
telomer
dloop
preferenti
unwound
wrn
blm
select
recogn
observ
suggest
involv
helicas
telomer
dna
repair
process
provid
secondari
structur
disrupt
studi
fancj
c
elegan
ortholog
suggest
also
enzym
involv
mainten
unstabl
genom
gc
rich
region
protect
delet
dna
process
limit
interstrand
crosslink
repair
formerli
believ
includ
pathway
dna
replic
particular
replicationblock
shown
intrins
mutagen
vivo
remov
genom
lack
yeast
helicas
effect
counteract
genet
instabl
grich
human
minisatellit
insert
yeast
genom
helicas
effect
construct
studi
mutat
exhibit
differ
gform
potenti
confirm
relationship
enzym
unwind
activ
effici
fold
human
enzym
protein
domain
involv
preferenti
resolvas
action
span
amino
acid
helicas
substrat
besid
grich
region
requir
singl
strand
dna
flank
tail
essenti
enzym
bind
target
lag
strand
dna
replic
protein
anoth
helicas
exhibit
nucleas
activ
yeast
human
enzym
confirm
preferenti
structur
specif
bind
effici
unwind
dna
structur
howev
nucleas
activ
reduc
fold
dna
arrang
restor
presenc
rpa
anoth
non
recq
helicas
isol
human
cell
resolvas
known
also
rhau
belong
aspglualahi
box
famili
select
identifi
use
affin
bead
presenc
atp
mg
physiolog
relev
process
wit
signific
drop
helicas
activ
toward
tetramolecular
follow
immunodeplet
use
monoclon
antibodi
rais
enzym
regul
decreas
biolog
process
almost
one
order
magnitud
interestingli
resolvas
activ
extend
also
rna
substrat
capabl
fold
tetraplex
bind
affin
select
found
locat
ntermin
rhau
specif
motif
conserv
region
evidenc
use
equival
drosophila
protein
share
dhx
aminotermin
domain
high
bind
affin
exhibit
toward
rna
k
pm
rang
suggest
structur
preferenti
recogn
dhx
may
repres
suitabl
vivo
target
uniqu
among
rna
helicas
recent
bind
grich
sequenc
telomeras
rna
htr
locat
termin
region
examin
accordingli
recognit
involv
helicas
domain
ntermin
accessori
domain
enzym
bind
specif
parallel
resolv
helicas
domain
process
affect
matur
htr
format
result
level
telomer
elong
telomeras
idea
follow
fold
may
protect
nascent
htr
degrad
subsequ
resolvas
action
favor
rna
elong
reach
matur
form
motif
modul
may
occur
also
viral
system
exampl
repres
larg
tantigen
helicas
multifunct
protein
requir
viral
replic
transform
besid
doublestrand
substrat
unwind
also
intramolecular
obtain
sequenc
occur
viral
genom
enzym
appar
bind
differ
dna
conform
similar
effici
perhap
use
differ
protein
domain
singl
strand
region
requir
effect
unfold
compact
structur
heterogen
nuclear
ribonucleoprotein
hnrnp
rna
bind
protein
particip
multipl
function
nucleic
acid
metabol
packag
nascent
transcript
altern
splice
translat
regul
character
distinct
featur
rna
bind
domain
contain
argglygli
rgg
box
auxiliari
domain
rich
specif
amino
acid
gli
aspglu
pro
also
abl
cross
nuclear
membran
distinct
hnrnp
motif
involv
destabil
fragil
x
repeat
sequenc
identifi
rat
liver
telomer
dna
bind
protein
mous
homologu
cbfa
well
member
famili
like
incident
differ
protein
domain
abl
stabil
rather
destabil
structur
form
telomer
repeat
ttaggg
n
hnrnp
consist
two
nucleic
acid
bind
domain
abl
recogn
human
telomer
repeat
ttaggg
n
nmr
studi
ctermin
bind
domain
complex
repeat
demonstr
upon
bind
protein
unfold
preform
quadruplex
telomer
dna
bind
linear
oligonucleotid
suggest
particip
hnrnp
protect
singlestrand
telomeras
templat
elimin
interfer
elong
telomer
dna
fold
transloc
event
similar
find
appli
ab
hnrnp
deplet
substanti
impair
telomeras
activ
restor
upon
addit
hnrnp
amino
acid
protein
nucleic
acid
anneal
activ
gel
retard
fret
spectroscopi
singl
molecul
fret
microscopi
confirm
hnrnp
bind
effici
singlestrand
gquadruplex
telomer
sequenc
particular
shown
telomer
fragment
bind
one
sever
hnrnp
molecul
gener
rather
tight
complex
structur
fact
suggest
bind
ribonucleoprotein
might
reduc
telomer
dna
access
actual
produc
telomer
protect
effect
rna
recognit
motif
hnrnp
contain
ntermin
amino
acid
domain
call
unwind
protein
protein
two
highli
conserv
argargmet
rna
bind
structur
motif
form
rigid
combin
entiti
fit
recognit
nucleic
acid
identif
binder
origin
studi
aim
select
protein
abl
bind
mous
hypervari
minisatellit
sequenc
known
fold
like
intramolecular
antiparallel
quadruplex
physiolog
condit
six
bind
protein
isol
cellular
extract
identifi
among
subsequ
electrophoret
mobil
shift
assay
reveal
tight
bind
nanomolar
k
oligonucleotid
hnrnp
addit
nucleoprotein
abolish
dna
synthesi
arrest
confirm
abil
unfold
architectur
contribut
preserv
genom
stabil
role
least
telomeras
regul
appear
quit
complex
inde
abl
enhanc
telomeras
activ
bell
shape
fashion
unfold
telomer
dna
also
recruit
telomeras
telomer
dna
fact
form
ternari
complex
telomeras
telomer
rna
nmr
chemic
shift
perturb
analysi
suggest
telomeras
rna
engag
binari
complex
addit
telomer
dna
produc
ternari
complex
displac
rna
site
henc
ribonucleoprotein
recruit
unfold
telomer
dna
telomeras
effect
bridg
incident
format
ternari
complex
may
explain
bell
shape
depend
telomeras
activ
upon
concentr
fact
optim
activ
depend
rel
ratio
ternari
complex
compon
simpli
monoton
function
compon
concentr
besid
telomer
genom
locat
exhibit
high
probabl
shown
comput
analysi
grich
region
found
mainli
locat
upstream
gene
transcript
start
site
henc
context
use
regul
gene
express
particular
almost
gene
contain
put
site
abundantli
oncogen
promot
oncosuppressor
gene
henc
particular
attent
devot
investig
effect
possibl
structur
modul
express
sever
oncogen
includ
cmyc
ckit
kra
prb
insensit
vegf
pdgf
repres
varieti
differenti
conform
featur
consid
doubl
helic
structur
stress
transcript
easili
compens
neg
superhel
local
fold
rememb
pyrimidin
c
rich
strand
fold
stabl
istructur
stabil
open
dna
form
yet
deepli
investig
oncogen
promot
cmyc
kra
thorough
review
state
art
concern
cmyc
see
among
protein
shown
play
import
role
bindingprocess
cmyc
non
metastat
protein
nucleolin
cellular
nucleic
acid
bind
protein
cnab
member
highli
conserv
famili
protein
kinas
critic
involv
cancer
develop
bind
cmyc
nucleas
respons
element
nhe
iii
sinc
recogn
singl
strand
purineor
pyrimidinerich
nucleic
acid
sequenc
promot
unfold
crich
structur
thu
allow
transcript
activ
oncogen
proteinmedi
unfold
confirm
fret
experi
sequenc
form
recogn
nucleolin
one
abund
non
ribosom
protein
eukaryot
particip
ribosom
biogenesi
cell
prolifer
multifunct
role
well
local
depend
upon
cellular
stress
condit
investig
delet
mutant
show
ctermin
region
protein
primarili
respons
bind
minim
recognit
structur
consist
two
rna
bind
domain
rgg
domain
particular
nucleolin
bind
stabil
nhe
iii
cmyc
promot
thu
might
act
oncosuppressor
decreas
promot
activ
depend
way
remark
nucleolin
bind
nhe
iii
hela
cell
point
vivo
signific
observ
interact
final
cellular
nucleic
acid
bind
protein
cnab
small
highli
conserv
singl
strand
nucleic
acid
dna
rna
bind
protein
involv
control
cell
prolifer
death
dimer
form
bind
rna
well
singlestrand
dna
grich
sequenc
cellular
target
includ
regulatori
element
gene
promot
mrna
untransl
region
upon
bind
nhe
iii
cnab
enhanc
cmyc
transcript
accord
data
thu
far
discuss
result
obtain
nucleolin
expect
melt
order
instead
appear
discrimin
parallel
antiparallel
fold
favour
former
henc
repres
yet
undisclos
gene
regul
mechan
wherebi
activ
repress
brought
switch
order
topolog
anoth
also
nucleas
hypersensit
element
nhe
hkra
shown
adopt
two
distinct
conform
identifi
parallel
mix
parallelantiparallel
form
nhe
bound
paramagnet
bead
isol
bind
protein
nuclear
extract
allow
identif
protein
bound
promot
like
poli
adpribos
hnrnp
henc
hnrnp
contribut
essenti
interact
telomer
level
see
also
target
grich
dna
sequenc
oncogen
promot
might
expect
kra
promot
effect
unwound
hnrnp
facilit
quadruplex
duplex
transit
prompt
synthesi
decoy
oligonucleotid
direct
interfer
hkra
promot
regul
bind
promot
recogn
protein
henc
repres
possibl
drug
direct
toward
krasrel
disord
sinc
oligonucleotid
maintain
stabl
conform
solut
effici
recogn
sequest
protein
target
modifi
r
phenylmethyl
glycerol
unit
tina
abl
stack
onto
tetrad
thu
stabil
modifi
decoy
test
pancreat
adenocarcinoma
cell
line
known
harbor
mutat
ra
gene
interestingli
show
remark
antiprolif
activ
submicromolar
ic
ga
rich
element
crucial
transcript
found
also
murin
kra
promot
pulldown
chromatin
precipit
studi
demonstr
recogn
mycassoci
zinc
finger
protein
maz
polymeras
particular
maz
bind
ga
element
doublestrand
structur
wherea
specif
latter
bind
protein
stoichiometri
vitro
protein
confirm
import
transcript
sinc
block
sirna
sequenc
transcript
effect
downregul
cmyb
oncogen
repres
peculiar
exampl
inde
spectroscop
mutagenesi
studi
consist
unusu
structur
assum
gga
repeat
deriv
stack
two
tetradheptad
sequenc
form
two
three
gga
repeat
delet
one
repeat
tetrad
increas
promot
activ
howev
complet
delet
gga
motif
impair
gene
transcript
clearli
show
grich
promot
sequenc
play
role
activ
repressor
addit
gga
region
recogn
maz
bind
gga
repeat
repress
promot
activ
murin
kra
maz
abl
recogn
doublestrand
dna
peculiar
describ
without
unfold
anoth
biochem
pharmacolog
signific
protein
vascular
endotheli
growth
factor
vegf
compel
biochem
biophys
evid
show
structur
form
vitro
vivo
sequenc
locat
growth
factor
promot
region
compris
four
run
three
contigu
guanin
separ
one
base
secondari
structur
form
complementari
crich
strand
character
intramolecular
imotif
involv
six
cec
pair
interestingli
grich
vegf
promot
region
recogn
bind
protein
nucleolin
case
cmyc
promot
conform
shift
control
gene
express
mechan
constrain
oncogen
extens
confirm
common
among
physiolog
pathway
ilpr
insulin
link
polymorph
region
noncod
minisatellit
upstream
human
insulin
promot
associ
genet
suscept
insulindepend
diabet
mellitu
contain
grich
tworepeat
sequenc
abl
adopt
intramolecular
conform
interestingli
insulin
tightli
bind
ilpr
sequenc
quadruplex
parallel
loop
like
recogn
insulin
b
chain
rais
possibl
direct
interact
promot
correl
gene
product
interestingli
besid
insulin
express
polymorph
ilpr
also
affect
adjac
gene
code
insulinlik
growth
factor
analog
insulin
bind
effici
ilprrel
confirm
possibl
interplay
gene
express
promot
regul
subsequ
studi
carri
analyz
interact
insulin
select
ilpr
variant
affin
maldi
surfac
plasmon
reson
techniqu
observ
k
valu
rang
show
remark
modul
natur
structur
possibl
power
detect
effici
bind
protein
digest
follow
maldi
detect
complex
show
gener
valcysglyasnargglyph
consensu
clear
whether
result
keep
insulin
b
chain
repres
major
bind
site
clearli
anoth
requir
ilpr
display
highaffin
bind
insulin
possibl
relat
hydrogen
bond
watsonecrick
interact
loop
compon
aca
tgt
furthermor
recognit
occur
effect
antiparallel
interest
mechan
gene
regul
propos
myogen
factor
mrf
initi
direct
myogenesi
mrf
heterodimer
eprotein
produc
ebox
motif
recogn
canntg
sequenc
muscl
tissu
differenti
gene
howev
homodimer
mrf
switch
bind
prefer
motif
rais
possibl
transcript
activ
might
modul
rel
homo
heterodim
distribut
presenc
would
favour
homodim
henc
act
transcript
silenc
factor
howev
case
sinc
substanti
enhanc
mrf
myod
ebox
driven
express
report
gene
luciferas
possibl
mechan
compat
find
envisag
structur
ebox
promot
recruit
transcript
ineffect
myod
homodim
presenc
eprotein
partner
myod
form
heterodim
releas
myogen
factor
bind
neighbor
ebox
motif
activ
transcript
gene
code
muscl
protein
nucleophosmin
phosphoprotein
abl
bind
rna
dna
rnase
activ
preferenti
cleav
prerrna
addit
involv
regul
tumor
suppressor
gene
mutat
ctermin
domain
observ
acut
myeloid
leukaemia
ctermin
domain
bind
dna
structuredepend
fashion
show
clear
prefer
arrang
interestingli
specif
sequenc
found
gene
promot
shown
select
target
protein
vivo
fold
physiolog
condit
interestingli
mutat
occur
leukem
phenotyp
map
bind
domain
produc
structur
destabil
protein
caus
aberr
behavior
genomewid
search
usual
consid
sequenc
potenti
form
fold
structur
least
three
stack
tetrad
grant
adequ
stabil
howev
investig
promot
ubiquit
enzym
human
thymidin
kinas
show
possibl
consist
two
tetrad
similarli
thrombin
aptam
inde
biophys
biochem
studi
confirm
stabl
quadruplex
fold
grich
promot
fragment
addit
report
gene
experi
cell
system
support
relationship
fold
state
test
promot
sequenc
level
gene
transcript
thu
evid
comprehens
search
take
account
flexibl
primari
dna
sequenc
requir
demand
near
futur
control
translat
protein
bind
untransl
rna
sequenc
rna
sequenc
recogn
depend
primari
secondari
structur
often
inform
posttranscript
regul
local
untransl
region
utr
mrna
particular
rna
regulatori
sequenc
locat
utr
like
play
role
translat
regul
rna
transport
seem
mostli
regul
sequenc
utr
mrna
even
sever
except
known
comput
approach
transcript
known
protein
code
gene
indic
high
incid
potenti
structur
utr
locat
sinc
grich
rna
sequenc
abl
fold
structur
similarli
dna
sequenc
occurr
utr
envisag
term
translat
repress
data
utr
bind
protein
could
modul
translat
process
other
transcript
henc
work
activ
repressor
rna
matur
exampl
avail
present
literatur
mani
expect
appear
near
futur
first
exampl
rna
abl
suppress
translat
process
origin
report
nra
utr
gene
found
bound
protein
conserv
across
eukaryot
involv
posttransl
mechan
translat
repress
decap
activ
ribonucleoprotein
degrad
protein
rna
bind
recent
demonstr
vitro
prefer
motif
includ
utr
nra
interestingli
tether
report
mrna
shown
repress
translat
might
expect
stabil
protein
second
exampl
deal
sar
coronaviru
uniqu
domain
sud
occur
highli
pathogen
speci
sud
fragment
sud
core
contain
residu
fulllength
domain
interact
effici
dna
rna
sequenc
fold
sinc
like
viral
protein
enter
nucleu
host
cell
access
target
mrna
sequenc
code
host
protein
would
allow
control
host
cell
respons
infect
anoth
case
concern
epstein
barr
viru
nuclear
antigen
virusencod
protein
essenti
genom
replic
mainten
latenc
link
region
known
involv
cellular
origin
recognit
complex
interestingli
particular
link
region
arginineand
glycinerich
henc
resembl
rgg
motif
known
oper
number
rna
bind
protein
fact
link
region
found
bind
grich
rna
sequenc
predict
adopt
fold
suggest
prolifer
mainten
viral
genom
mediat
rna
recognit
addit
well
establish
exampl
refer
neurolog
patholog
call
fragil
x
syndrom
fx
recogn
common
inherit
form
mental
retard
genet
character
expans
number
cgg
repeat
utr
gene
healthi
individu
sick
peopl
abnorm
expans
produc
hypermethyl
silenc
gene
lead
loss
fragil
x
mental
retard
protein
fmrp
patholog
condit
grich
expand
repeat
occur
genom
dna
noncod
strand
rna
level
could
exploit
modul
express
translat
assess
function
consequ
hypothesi
long
cgg
sequenc
contain
repeat
posit
upstream
report
gene
effici
reduc
mrna
translat
depress
mrna
util
human
cell
transfect
plasmid
bear
promoterdepend
report
gene
parallel
gquadruplex
disrupt
protein
hnrnp
cbfa
effect
increas
report
mrna
translat
wherea
protein
mutant
unabl
unwind
inact
emerg
mechan
forese
translat
block
produc
fold
structur
long
cgg
repeat
sequenc
revers
unwind
protein
protein
fmrp
autosom
paralog
bind
effici
rna
rgg
box
without
requir
addit
bind
motif
stem
junction
shown
sever
spectroscop
techniqu
bind
still
sustain
arg
residu
rgg
box
four
arg
residu
posit
methyl
posttransl
interestingli
number
arg
requir
rna
bind
depend
upon
natur
target
rna
exampl
first
two
residu
requir
polyribosom
associ
recognit
mrna
associ
thu
role
methyl
regul
bound
rna
envisag
sever
protein
bind
cgg
n
repeat
identifi
unfold
trinucleotid
repeat
revers
dna
synthesi
arrest
sequenc
distinct
behaviour
telomer
dna
bind
protein
rat
homologu
mous
cbfa
previous
identifi
singlestrand
quadruplex
telomer
dna
bind
protein
fact
stabil
human
telomer
repeat
destabil
cgg
repeat
henc
dna
sequenc
bind
differ
protein
domain
frax
anoth
form
mental
retard
due
impair
gene
function
gene
product
yet
fulli
understood
protein
specif
effect
bind
rna
addit
enhanc
action
locat
mrna
altern
splice
exon
reduc
suggest
protein
involv
control
altern
splice
thorough
discuss
role
rna
metabol
use
fmrp
paradigmat
exampl
highlight
princip
aspect
posttranscript
gene
express
fmrp
particip
translat
regul
altern
splice
process
final
worth
recal
alway
possibl
predict
bind
prefer
monitor
presenc
conserv
protein
structur
domain
exampl
preced
report
rgg
box
appear
repres
gener
select
bind
motif
howev
rule
sinc
rgg
herp
simplex
protein
bind
flexibl
non
rna
structur
larg
bodi
inform
avail
small
molecul
structur
function
pharmacolog
studi
basic
chemic
requir
effect
recognit
small
molecul
dissect
larg
extent
modellingstructur
studi
give
use
hint
specif
ligandenucl
acid
interact
binder
clearli
larg
potenti
therapeut
agent
first
telomeredirect
compound
behav
antiprolif
agent
interf
telomeraseact
organ
system
exhibit
altern
mechan
telomer
mainten
exploit
inhibit
telomeras
function
first
case
telomer
dysfunct
second
result
known
ligand
consid
cancer
treatment
interestingli
also
gener
grich
oligonucleotid
behav
antiprolif
agent
among
possibl
mechan
might
impli
competit
effect
recognit
interfer
biolog
process
given
ubiquit
although
random
occurr
motif
genom
rna
transcript
bind
agent
expect
caus
number
side
effect
impair
sever
physiolog
process
relat
diseas
henc
unwant
toxic
expect
addit
fold
show
remark
polymorph
dna
one
hand
might
improv
differenti
target
among
topolog
form
might
render
nucleic
acid
target
illdefin
henc
elus
rel
poor
specif
ligand
direct
might
turn
strong
one
consid
complex
novel
drug
target
similarli
wellknown
proteinenucl
acid
complex
exploit
drug
target
dnatopoisomeras
cleavag
complex
select
could
gener
drug
featur
recogn
interfac
principl
affect
stabil
binari
complex
stabil
destabil
effect
could
envisag
ternari
complex
format
drug
competit
bind
site
andor
alloster
effect
strengthen
impair
quadruplexrel
biolog
respons
includ
also
interfer
mechan
protein
homoand
heterodim
format
known
particip
sever
critic
regulatori
process
convers
destabil
unwant
fold
may
carri
devis
ligand
tether
stabil
singl
strand
bind
proteineunfold
nucleic
acid
complex
structur
inform
latter
type
complex
readili
avail
literatur
littl
threedimension
inform
avail
protein
bound
complex
therefor
present
easi
pinpoint
precis
structur
featur
involv
bind
specif
nucleic
acid
side
quadruplex
scaffold
consid
central
core
like
flower
corolla
petal
repres
loop
character
direct
number
natur
connect
base
abl
mediat
select
recognit
target
protein
way
reminisc
antigen
bind
antibodi
connect
mani
aptam
identifi
investig
drug
diagnost
agent
far
newli
emerg
target
grich
complementari
strand
doublestrand
chromatin
crich
sequenc
known
fold
imotif
fourstrand
structur
consist
parallelstrand
duplex
zip
togeth
antiparallel
orient
intercal
hemiproton
cytosin
ecytosin
base
pair
found
gene
promot
cmyc
ilpr
imotif
besid
repres
per
se
potenti
drug
target
might
also
recogn
nucleic
acid
bind
protein
complex
repres
uniqu
featur
highli
specif
ternari
interact
addit
recent
shown
eukaryot
telomer
transcrib
telomer
repeat
contain
rna
terra
telomer
tractderiv
repeat
span
base
abl
fold
full
rna
structur
rnadna
intermolecular
hybrid
terra
appear
particip
telomer
dna
replic
heterochromatin
format
telomeras
regul
number
terrabind
protein
includ
htert
identifi
suggest
possibl
exist
terra
recogn
protein
henc
possibl
select
modul
terra
function
disrupt
stabil
complex
medic
applic
binari
complex
might
specif
target
drug
molecul
combin
efficaci
select
treat
seri
sever
diseas
start
cancer
telomer
oncogen
promot
target
mental
condit
fragil
x
diabet
ill
associ
autosom
recess
mutat
gene
code
helicas
known
binder
alreadi
shown
interfer
particular
system
mani
essenti
employ
biochem
tool
could
possibl
turn
drug
behav
effect
modul
biolog
respons
turn
specif
topolog
could
stabil
solut
chemic
modif
natur
occur
oligonucleotid
act
decoy
pharmacolog
applic
conclus
medicin
chemist
amaz
varieti
opportun
drug
discoveri
offer
excit
fast
grow
field
research
world
